This Article  • Full text  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (5)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Psychiatry  • Attention Deficit Hyperactivity Disorder  • Alert me on articles by topic

Arch Pediatr Adolesc Med. 1999;153:1220-1221.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE STUDY by Zito and colleagues¹ in this issue of the ARCHIVES is a welcome first step in understanding the clinical use of stimulant medications in the treatment of attention-deficit/hyperactivity disorder (ADHD). The controversy about treatment with methylphenidate hydrochloride raised in the popular press^2-3 continues despite the fact that ADHD and its treatment with stimulant medications and psychosocial interventions have been rigorously studied to a greater degree than any other mental disorder.^4-5 The continued concern is the perception that too many children are being treated with stimulant medication.⁶ The evidence to date suggests that, while there may be inappropriate treatment with methylphenidate as implied by the wide variation in physician and local prescription rates,⁷ the variations include both undertreatment and overtreatment such that the prevalence of stimulant medication use does not exceed the most commonly accepted prevalence rates for the disorder.^8-9 The study by Zito et al further substantiates these . . . [Full Text of this Article]

RELATED ARTICLE

Psychotherapeutic Medication Patterns for Youths With Attention-Deficit/Hyperactivity Disorder
Julie Magno Zito, Daniel J. Safer, Susan dosReis, Laurence S. Magder, James F. Gardner, and Deborah A. Zarin
Arch Pediatr Adolesc Med. 1999;153(12):1257-1263.
ABSTRACT | FULL TEXT